OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

EPA and DHA differentially modulate membrane elasticity in the presence of cholesterol
Miranda L. Jacobs, Hammad A. Faizi, Justin A. Peruzzi, et al.
Biophysical Journal (2021) Vol. 120, Iss. 11, pp. 2317-2329
Open Access | Times Cited: 58

Showing 1-25 of 58 citing articles:

The dawn of a new era of targeted lipid-lowering therapies
Lâle Tokgözoğlu, Peter Libby
European Heart Journal (2021) Vol. 43, Iss. 34, pp. 3198-3208
Open Access | Times Cited: 111

Role of Omega-3 Fatty Acids in Cardiovascular Disease: the Debate Continues
Samuel Sherratt, Peter Libby, Matthew J. Budoff, et al.
Current Atherosclerosis Reports (2022) Vol. 25, Iss. 1, pp. 1-17
Open Access | Times Cited: 77

EPA and DHA containing phospholipids have contrasting effects on membrane structure
Samuel Sherratt, Rebecca A. Juliano, Christina Copland, et al.
Journal of Lipid Research (2021) Vol. 62, pp. 100106-100106
Open Access | Times Cited: 56

Review of Eukaryote Cellular Membrane Lipid Composition, with Special Attention to the Fatty Acids
Omeralfaroug Ali, András Szabó
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15693-15693
Open Access | Times Cited: 38

Do patients benefit from omega-3 fatty acids?
Samuel Sherratt, R. Preston Mason, Peter Libby, et al.
Cardiovascular Research (2023) Vol. 119, Iss. 18, pp. 2884-2901
Open Access | Times Cited: 26

Omega-3 fatty acids for cardiovascular event lowering
Gurleen Kaur, R. Preston Mason, Philippe Gabríel Steg, et al.
European Journal of Preventive Cardiology (2024) Vol. 31, Iss. 8, pp. 1005-1014
Open Access | Times Cited: 15

The Protective Effect of Docosahexaenoic Acid on Mitochondria in SH-SY5Y Model of Rotenone-Induced Toxicity
Britta Eggers, Jennifer Stepien, Anne-Katrin Reker, et al.
Metabolites (2025) Vol. 15, Iss. 1, pp. 29-29
Open Access | Times Cited: 1

Omega-3 and omega-6 fatty acids have distinct effects on endothelial fatty acid content and nitric oxide bioavailability
Samuel Sherratt, Hazem Dawoud, Deepak L. Bhatt, et al.
Prostaglandins Leukotrienes and Essential Fatty Acids (2021) Vol. 173, pp. 102337-102337
Open Access | Times Cited: 42

The impact of lipid polyunsaturation on the physical and mechanical properties of lipid membranes
Rim Baccouch, Yarong Shi, Emilie Vernay, et al.
Biochimica et Biophysica Acta (BBA) - Biomembranes (2022) Vol. 1865, Iss. 2, pp. 184084-184084
Open Access | Times Cited: 37

Effects of omega-3 fatty acids on coronary revascularization and cardiovascular events: a meta-analysis
Monica Dinu, Francesco Sofi, Sofia Lotti, et al.
European Journal of Preventive Cardiology (2024)
Open Access | Times Cited: 8

Beyond LDL-C: unravelling the residual atherosclerotic cardiovascular disease risk landscape—focus on hypertriglyceridaemia
Bilal Bashir, Jonathan Schofield, Paul Downie, et al.
Frontiers in Cardiovascular Medicine (2024) Vol. 11
Open Access | Times Cited: 8

The crosstalk between extracellular matrix proteins and Tau
Subashchandrabose Chinnathambi, Smita Eknath Desale
Advances in protein chemistry and structural biology (2024), pp. 447-466
Closed Access | Times Cited: 6

A biological rationale for the disparate effects of omega-3 fatty acids on cardiovascular disease outcomes
Samuel Sherratt, Peter Libby, Deepak L. Bhatt, et al.
Prostaglandins Leukotrienes and Essential Fatty Acids (2022) Vol. 182, pp. 102450-102450
Open Access | Times Cited: 26

Omega-3 and cardiovascular prevention – Is this still a choice?
Massimiliano Ruscica, Cesare R. Sirtori, Stefano Carugo, et al.
Pharmacological Research (2022) Vol. 182, pp. 106342-106342
Open Access | Times Cited: 23

Omega-3-fatty acids: Do they prevent cardiovascular disease?
R. Preston Mason, Samuel Sherratt, Robert H. Eckel
Best Practice & Research Clinical Endocrinology & Metabolism (2022) Vol. 37, Iss. 3, pp. 101681-101681
Open Access | Times Cited: 21

Cholesterol crystals and atherosclerotic plaque instability: Therapeutic potential of Eicosapentaenoic acid
M. John Chapman, R. Preston Mason
Pharmacology & Therapeutics (2022) Vol. 240, pp. 108237-108237
Closed Access | Times Cited: 21

Eicosapentaenoic acid (EPA) reduces pulmonary endothelial dysfunction and inflammation due to changes in protein expression during exposure to particulate matter air pollution
Samuel Sherratt, Peter Libby, Hazem Dawoud, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 162, pp. 114629-114629
Open Access | Times Cited: 13

Geometrical isomerization of arachidonic acid during lipid peroxidation interferes with ferroptosis
Yusuke Hirata, Carla Ferreri, Yuto Yamada, et al.
Free Radical Biology and Medicine (2023) Vol. 204, pp. 374-384
Open Access | Times Cited: 11

Polyunsaturated fatty acids suppress PIEZO ion channel mechanotransduction in articular chondrocytes
Gabrielle K. Marushack, Alireza Savadipour, Ruhang Tang, et al.
The FASEB Journal (2025) Vol. 39, Iss. 1
Closed Access

Essential lipids enrich membrane-associated condensates to rescue synaptic morpho-functional deficits in a mouse model of autism
Jason Arsenault, Tian Fook Kong, Rayan Saghian, et al.
Cell Reports (2025) Vol. 44, Iss. 5, pp. 115573-115573
Closed Access

The effects of molecular and nanoscopic additives on phospholipid membranes
Teshani Kumarage, Nicholas B. Morris, Rana Ashkar
Frontiers in Physics (2023) Vol. 11
Open Access | Times Cited: 10

Effects of APOE4 on omega-3 brain metabolism across the lifespan
Brandon Ebright, Marlon Vincent V. Duro, Kai Chen, et al.
Trends in Endocrinology and Metabolism (2024) Vol. 35, Iss. 8, pp. 745-757
Closed Access | Times Cited: 3

Exploring neutrophils as therapeutic targets in cardiometabolic diseases
Mattia Albiero, Andrea Baragetti
Trends in Pharmacological Sciences (2025)
Closed Access

Page 1 - Next Page

Scroll to top